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Introduction
Minimal cell research has gained considerable interest in
recent years.[1] Successful realization of which could open up
the possibilities of not only a deeper understanding of biologi-
cal cell complexities but also for engineering new artificial cells
designed with specific tasks in mind. The “top-down” approach
aims to reach this goal through the modification of pre-exist-
ing organisms. The “bottom-up” approach, on the other hand,
hopes to achieve this goal by assembling an artificial cell from
individual non-living components.[1] The latter method, al-
though it may take longer to reach the goal, gives us the op-
portunity for complete control of the system, which may lead
to a broader range of future applications.
Theoretically, the construction of a minimal cell from the
bottom-up should be possible by mimicking and redesigning
what we see in nature using individual components, such as
sugars, lipids, proteins, and genetic material.[2] Before these
steps can take place, a suitable compartment system to con-
tain these materials should be established. Among all the
choices, lipid vesicles remain the most likely candidates to suc-
ceed. These vesicular structures are composed of phospho-
lipids and come in various sizes, such as small unilamellar vesi-
cles (SUVs) below 100 nm diameter, large unilamellar vesicles
(LUVs) from 100—1000 mm, and giant unilamellar vesicles
(GUVs) between 1 and approximately 100 mm.[3–5] GUVs are
considered the gold standard of cellular mimics owing to their
similarity in size to that of a mammalian cell. Moreover, with
advances in technologies, such as microfluidics for their pro-
duction[6] and handling,[7] GUVs are looking like an increasingly
more attractive option.
The challenge lies in not only encapsulating large biomole-
cules inside giant vesicles (something which not all GUV prepa-
ration techniques can achieve), but also in establishing a reli-
able method for their production. Having biomolecules, such
as actin networks or proteins in general on the inside of lipid
vesicles is an essential requirement for the bottom-up con-
struction of artificial cells. High protein encapsulation is also of
interest for biophysical studies when their interaction with
inner leaflet plasma membranes lipids is under investiga-
tion.[8–11] Moreover, techniques, which allow encapsulation of
low samples volumes are often desirable. Unfortunately, con-
ventional techniques do not readily yield the encapsulation of
large biomolecules and do not offer control over size or
yield.[12–14] Recently, microfluidic systems have been demon-
strated as excellent platforms for the preparation of monodis-
perse liposomes with high precision lossless encapsulation of
biomolecules.[15–17] The most common methods being double
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emulsion templating by co-axially aligned glass capillaries.[18–20]
Alternative microfluidic techniques include cDICE,[21] jetting,[22]
and pico-injection.[23] For a more detailed review of these
methods please refer to references [17] and [24] . Although mi-
crofluidic devices do yield GUVs, which are more monodisperse
in size and with higher encapsulation efficiencies, their use in-
volves more complex instrumental or time-consuming setups,
which are not always available to researchers.[6, 25–27] On the
contrary, the bulk inverted emulsion-based method has shown
great promise in encapsulating macromolecules, such as poly-
mers,[28] DNA,[29] enzymes,[30] cells,[31] and even micron-sized
particles.[32] The method can also be used to produce GUVs
with complex multicomponent lipid mixtures allowing them to
be used as biomimetic membrane models.[33,34]
Despite this, the method suffers from a few drawbacks re-
sulting in poor yields or insufficiently large GUVs. For this
reason, very few groups have adopted the method and often
prefer more established techniques, such as electroformation
or gentle hydration,[4, 5, 14] even if these choices limit the range
of experimental possibilities. This paper aims to address this
issue by optimizing each of the required steps in the inverted
emulsion method to maximize the yield and reliability. Normal-
ly, it is performed in Eppendorf tubes resulting in one prepara-
tion of GUVs. Not only is this low-throughput, but in the ab-
sence of proper optimization, results in very low vesicle yields.
Recently, we presented work in which we demonstrated that
microtiter plates are ideal for performing this method as it
allows multiple parallel experiments.[29] We take advantage of
this setup within this work and perform repeatable parallel ex-
periments to allow optimization.
The typical procedure (Figure 1a) starts with the initial disso-
lution of a specific concentration of a chosen lipid mixture in
oil (such as mineral oil or mixture of multiple oils) that is later
added on top of an aqueous solution to form an oil–water
interface. The lower aqueous solution will eventually become
the outer environment of the GUVs (typically a glucose solu-
tion). At the same stage, a specific volume of denser aqueous
solution is added to the lipid–oil phase (in a separate vial) to
produce a water-in-oil emulsion. This aqueous phase will
become the inner compartment of the GUV and will therefore
contain the solutes to be encapsulated. Owing to their amphi-
pathic nature, lipids present in the oil phase self-assemble at
the interfaces (both the emulsion and the lower interfacial
layer, see Figure 1a) to form lipid monolayers. The emulsion is
then added on top of the interface and a centrifugal force is
applied to assist the movement of denser water-in-oil emulsion
droplets through the interfacial lipid monolayer. This process
will result in the simultaneous wrapping of the second mono-
layer of lipids around the droplets and the formation of GUVs
in the lower aqueous phase. Serious consideration should be
made to ensure the fact that the oil used to solubilize the
lipids can remain in between the lipid leaflets, which can alter
the natural physical properties of the membrane.[35–37] Any pro-
tocol, which uses an oil phase to form lipid membranes should
have the membrane inspected. This could be one of the major
reasons for lack of widespread acceptance and usage of this
method, even though a couple of studies have shown no
significant changes in the membrane mechanics of GUVs pre-
pared from inverted emulsions.[38,39] In addition to this, the
method must be optimized for compatibility with a range of
salt concentrations and pH values, as well as having charged/
uncharged macromolecules inside or outside the GUVs to
make them as biomimetic as possible.
To the best of our knowledge, an extensive systematic study
of the various parameters that might affect the production of
GUVs using this method has not been attempted previously. In
this paper, we analyze the resulting vesicles with respect to
their size and yield by thoroughly optimizing each preparation
step. We investigate the significance of the applied force, cen-
trifugation duration, the inner solution density/composition,
the monolayer formation time, oil phase, lipid concentration,
pH, droplet volume, and temperature. Importantly, we confirm
the applicability of the GUVs by characterizing their membrane
functionality and property by performing a membrane protein-
based permeation assay as well as bending rigidity measure-
ments. Finally, the method can be performed within microtiter
well plates for high-throughput production and analysis.
Results and Discussion
The multiple steps involved in this inverted emulsion method
can lead to unseen errors (Figure 1b and c) which may lead to
low yields. So here, we optimize each step systematically to
identify the most crucial ones and the effects they have on the
morphology as well as the yield of the GUVs. Performing the
method within microtiter plates allows us to run multiple par-
allel conditions for fast optimization. Here, we focus on the
effects of density gradients of the aqueous solutions, the time
and speed of centrifugation, the concentration of the lipids,
Figure 1. Overview and the pitfalls of the inverted emulsion method.
a) Schematic representation of the five steps of the inverted emulsion
method with the ideal GUV production. Parameters, such as b) low lipid con-
centrations and insufficient incubation times may result in an incomplete
interfacial lipid monolayer that can compromise overall GUV yield and size.
c) Centrifugation speed and duration also have an impact on the morpholo-
gy and yield of the GUVs as the droplets may remain in the oil phase or at
the interface.
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the incubation time for the formation of lipid monolayer at the
interface, the type of the inner solution, and the role of pH
and temperature during the formation of the GUVs.
Sugar-based density gradients
Sugars, such as glucose and sucrose, have been extensively
used in the preparation of giant vesicles to maintain isoosmot-
ic conditions across the membrane and also for their relative
inertness towards the lipid bilayer. In the case of the inverted
emulsion method, the inclusion of a density gradient between
the lipid oil and the inner aqueous solution is essential for the
formation of GUVs. The water-in-oil droplet has to be trans-
ferred from the oil phase to the aqueous phase. Most natural
oils are of low density compared to pure water and mineral oil,
used primarily in this study, is no exception. Furthermore,
there is another density gradient to be taken into consider-
ation—the density difference between the inner aqueous solu-
tion and the outer aqueous solution. This allows the GUVs to
settle at the bottom of the well not only for instant visualiza-
tion but to avoid aggregation at the interface—made possible
if the outer aqueous solution is less dense compared to the
inner aqueous solution present inside the droplets (and even-
tually inside the GUVs). Some researchers have used gravity to
provide the force to drive the droplets through the interface.[40]
This method of production not only requires a significant den-
sity gradient, but also needs a longer time for all the droplets
to cross through the lipid monolayer to obtain a good yield.
Alternatively, this process can be expedited by applying a cen-
trifugal force, as performed herein.
From Figure 2a, it is evident that there is a significant in-
crease (at least ~ fivefold) in the number of GUVs produced
when the inner sucrose solution concentrations are equal to
300 mm or above compared to 50 mm at any given applied
centrifugal force. Note that glucose at an isoosmolar concen-
tration is used as the outer solution throughout unless other-
wise stated. Furthermore, increasing the centrifugal force
applied for a specific time (here it was fixed at 3 min) is also
effective in improving the number of GUVs produced until it
plateaus at 400g. However, it should be noted that high centri-
fugation speeds (above 300g) result in clustering of GUVs at
the cover glass and formation of lipid clumps due to bursting
(Figure 2c and Figure S1 in the Supporting Information). The
average sizes of the giant vesicles produced tend to remain
approximately the same for all the sugar concentrations and
applied centrifugal forces tested. The range was between 20–
35 mm in diameter, except for a 50 mm sugar concentration
where some were less than 20 mm (Figure 2b). Note that vesi-
cles smaller than 10 mm are excluded from our analysis. We
conclude that a denser inner solution promotes better yields
due to a larger force experienced by each droplet. We specu-
late that the size variation for low sugars may be because
larger GUVs do not survive or that the droplets did not make it
through the interface. For the next experiments, we chose
600 mm sucrose as the optimal sugar concentration, that is,
high yield, large GUVs, and minimum bursting. Although this
ideal sugar concentration is higher than physiological osmolari-
ties (~260 to >400 msOm depending on the cell), more rele-
vant concentrations of 300 mm also produce good yields.
Centrifugal duration
From the above data it is evident that the inverted emulsion
method is highly dependent on the density of the solutions
used. Whereas a higher centrifugal speed for a short span of
time might be enough to force all the droplets to pass
through the lipid interface, our data suggest that it will also
result in bursting and aggregation of the GUVs along the walls
of the microtiter plate (see 1200g centrifugal speed for 10 min
in Figure S2). Therefore, we aimed at achieving good yields at
lower speeds but with longer time durations as shown in
Figure 3.
As expected, the yield increased with increasing duration of
centrifugal force applied (Figure 3a). This is to be expected as
a longer applied force will increase the chances of the droplets
crossing over the interface. Figure 3a also shows that the yield
of GUVs remains highest with a minimum of 3 min and above
200g. This can be advantageous if speed of encapsulation is
crucial. Furthermore, as the yield of the GUVs remained the
same for higher forces it suggests that most of the droplets
have passed through the interface (for this specific volume of
emulsion droplets and solution density gradient). However, the
plateau in yield could also be a result of 1) bursting of large
vesicles at the glass well bottom due to higher forces and/or
2) the interfacial monolayer not having enough time to re-seal
before the next droplet arrives. We note that although the
yield and size of the GUVs are superior from 600g and above
for all durations (see Figure S2 for images), fewer lipid aggre-
gations occur at 200g for 3 min (Figure 3c). Considering this
Figure 2. Yield and size distribution of 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) GUVs produced by varying the inner solution densi-
ty and at multiple centrifugation speeds. a) Yields obtained for each concen-
tration of inner sucrose solution tested at various centrifugation speeds. See
the Experimental Section for yield calculation details. b) Size of the GUVs at
different sugar concentrations and applied centrifugation speeds (n=3).
c) Confocal images of GUVs containing 600 mm sucrose solution at various
centrifugation speeds. Note that at 400g bursting occurs. Here, the inner
volume was 5 mL and the incubation time for the interface formation was
30 min with a lipid concentration of 400 mm. Scale bars : 50 mm.
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observation, we have chosen to use 3 min of 200g centrifuga-
tion speed for the proceeding experiments.
Volume of inner solution
It is easy to predict that the GUV yield depends on the number
of water-in-oil droplets. Therefore, we varied the volume of the
inner aqueous solution used to produce the initial emulsion.
Note that all other volumes were kept constant and the same
total volume of 50 mL of emulsion was added. We used inner
solution volumes from 1 to 25 mL and as Figure 4 shows, the
yield increased with volumes between 5 and 10 mL. The size of
the vesicles, however, peaked at 25 mL inner solution volume.
It is reasonable to assume that the yield decreases with smaller
volumes of the inner solution supplied for creating the emul-
sion, but it was unexpected that it decreases again at greater
volumes. This phenomenon can be attributed to the fact that
a higher volume of inner solution produces more droplets
with increasing proximities to each other. This could result in a
higher probability of spontaneous droplet fusion leading to
larger vesicles but lower overall numbers. Indeed, this was ob-
served in the case of 25 mL whose average diameter is 1.5-fold
more than the other conditions (Figure 4b and c).
Consequentially, these results suggest an opportunity to
tune the size of the GUVs to an extent by changing the
volume of the inner solution to make the emulsion. Neverthe-
less, for the next experiments, we selected 7 mL for the inner
solution volume as it produces the highest number of GUVs
with the least variation in GUV size.
Lipid concentration and incubation time
The concentration of solubilized lipids in the oil phase directly
affects the time it takes to form the monolayers at the oil–
water interfaces. This, in turn, puts a limit on the speed of the
overall preparation time, which can be a disadvantage without
optimization. Moreover, an incomplete lipid monolayer at the
interface can directly affect the yield of the GUVs produced.
For example, the aqueous interior of the droplets can make
direct contact with the aqueous outer solution instead of the
lipid monolayer at the interface resulting in the unwanted re-
lease of internal contents and reduction in the overall yield.
Therefore, it is important to have a sufficiently assembled inter-
facial lipid monolayer before addition of the emulsion. In
Figure 5, we explored the minimal required total concentration
of lipids in the oil phase to help form a complete interfacial
monolayer at the shortest possible time while still providing
good GUV yields. For the various lipid concentrations tested
(50, 100, 200, 400, and 800 mm), the GUV yield increases with
the lipid concentration with any given period of incubation
(Figure 5a). Confocal images for 200 mm in Figure 5c also show
that a longer period of incubation results in better monolayer
formation and yield (for images of other conditions see Fig-
ure S3). However, the data also reveals that if the lipid concen-
Figure 3. Plots of a) GUV yields and b) sizes produced at different centrifuga-
tion time periods and speeds. c) Confocal images of GUVs produced at 200g
centrifugation speed for various time periods. DiIIC18 was used as a mem-
brane stain to visualize the GUVs. Note that error bars are taken from the
standard deviations throughout (n=3). These results were obtained for
fixed 600 mm sugar solutions, 5 mL inner volume, incubation time for the in-
terface formation of 30 min, and with a lipid concentration of 400 mm. Scale
bars : 50 mm.
Figure 4. Plots presenting the effect that the inner solution volume used to
make water-in-oil droplet emulsions has on a) the yield and b) the average
size distribution of the GUVs. c) Confocal images of GUVs with 600 mm su-
crose produced at 200g speed for 3 min (n=3). Scale bars: 50 mm.
Figure 5. Plots of the a) yield and b) size distribution of the GUVs produced
with various lipid concentrations in mineral oil and at different incubation
time periods. c) Confocal images of GUVs with 600 mm sucrose solution pro-
duced at 200g for 3 min with 200 mm lipid concentration in mineral oil (n=
3). Scale bars : 50 mm.
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tration is too low (<200 mm), it is not possible to increase the
overall yield with a longer incubation time (Figure 5a). Presum-
ably due to the unavailability of lipids needed to cover the
interfacial area of the well completely and to replenish it after
droplet crossing. To confirm this assumption with a high
degree of certainty, one would have to perform complementa-
ry simulations to investigate the minimum time required for
the lipids to re-assemble at the interface after droplet crossing.
For higher lipid concentrations (200, 400, and 800 mm), the
yield is similar and reached a plateau with a minimum of
30 min incubation time.
Considering this finding, for the next optimization we have
fixed the interfacial lipid monolayer incubation time at 30 min
and the lipid concentration at 200 mm. In addition, the range
of sizes is similar to that of the experiments performed earlier
in this work (~20–30 mm in diameter), which demonstrates the
robustness of the method in general (Figure 5b).
Effects of pH and temperature
pH and temperature play a crucial role in the functionality of
many biological processes.[41] As model membranes for biologi-
cal cells, giant vesicles have been shown to be robust at vari-
ous physiologically relevant pH and temperature ranges.[42]
Considering that this emulsion-based method has the advant-
age of encapsulating large biomolecules such as enzymes,[30] it
is therefore possible to study the enzymatic activity of biologi-
cally relevant chemical reactions encapsulated within. To deter-
mine if it is possible to produce GUVs at such conditions, we
prepared GUVs at various pH (inside and outside) and temper-
ature conditions. Figure 6 shows the change in yield and size
with varying temperatures and pH conditions. Yields moder-
ately increased from pH 4 to 9 and decreased significantly at
pH 12 (Figure 6a). This can be explained due to the fact that at
low and high pH values, the zwitterionic POPC lipid headgroup
becomes more positively or negatively charged, respectively.[43]
It is known that charged lipids in monolayers repel each other,
which may affect the formation and stability of the final GUVs.
Moreover, at pH 12, the vesicles were larger with clustering
and aggregation (Figure 6b and c). This is most likely due to
the hydrolyzing effect induced by hydroxide ions and possible
degradation of the lipids at such high pH environments.[44] In a
further experiment to ascertain the greater applicability of the
method for producing biomimetic compartments we used the
buffering agents 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), Tris, and phosphate-buffered saline (PBS) within
inner solution only. Figure S4 shows that the method can pro-
duce GUVs containing these widely used buffers—something
which is not always feasible with hydration-based methods
especially in the case of salt containing PBS solutions.
Unlike pH, temperature does not seem to have a drastic
impact on the overall yield of the GUVs (Figure 6d). The yield
appears to increase marginally with temperature, at least for
the one component POPC lipid composition implemented
here. Although the maximum temperature used in this study
(37 8C) yielded a higher number of GUVs, the average size of
the GUVs ((23:4) mm) was smaller than the average size of
the GUVs ((30:4) mm) produced at rest of the temperature
conditions (Figure 6e). Visually, the GUVs produced at all the
temperatures tested were without defects or aggregations
except at 37 8C where some small lipid clumps were seen (ob-
served as bright red spots in Figure 6 f). From the results ob-
tained, the inverted emulsion method can successfully produce
biomimetic GUVs at different pH and temperature condi-
tions—including physiological ones.
Polymers as alternative density gradient agents
As already shown, the density of the inner solution is vital for
producing GUVs using the inverted emulsion-based method. A
denser inner solution can easily pass through the oil phase
and across the oil–water interface. Furthermore, a denser inner
solution will help the GUVs settle down to the bottom of the
well plate for better visualization and long-term experiments.
The above experiments encapsulated sugar-based aqueous
solutions to not only achieve this density difference, but also
to osmotically balance the medium. The usage of sugar solu-
tions might not be feasible if one has to encapsulate enzymes
that can metabolize sugars or molecules that are sensitive to
these carbohydrates. Moreover, encapsulating cells within
GUVs for single-cell analysis, which has gained some interest in
Figure 6. The yields and sizes of the GUVs produced at different a), b) pH
and d), e) temperature conditions. Confocal images of these GUVs acquired
for c) pH 4, 7, 9 and 12 and f) temperatures 4, 10, 25, and 37 8C (n=3). Scale
bars : 50 mm.
ChemBioChem 2019, 20, 2674 – 2682 www.chembiochem.org T 2019 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim2678
Full Papers
recent years[31] and high concentrations of sugars can affect
cell viability or function.
In such scenarios, alternative compounds that will not ad-
versely affect the lipid bilayer have to be implemented. Consid-
ering this, we have turned to polymers, such as polyethylene
glycol (PEG) and poly(vinyl alcohol) (PVA). PEG is a well-known
compound with high hydrophilicity and anti-biofouling proper-
ties.[45] Elsewhere, PVA is used as a coating material to grow
GUVs using the gentle hydration method.[46] Figure 7 depicts
the yield and size of the GUVs produced at various polymer
concentrations used as an inner solution (osmotically matched
glucose outside) at different spin speeds. As expected, the
GUVs yield increased with higher concentration of the poly-
mers in the inner solution as the densities increased (Figure 7a
and d). Note that for concentrations of 0.5 to 5% the osmolari-
ties increased from 1 to 45 mOsm and 4 to 60 mOsm for PEG
and PVA, respectively. At 400g, the yield reached a plateau for
both the polymers whereas the average size of the GUVs re-
mained the same for all the concentrations at that spin speed.
We also observed that the vesicles encapsulating PEG exhibit
inward tubes, consistent with recent findings for stabilization
of high spontaneous curvature by this polymer.[47,48] Surprising-
ly, from 300 to 500g, the average size of the GUVs (~25 mm) is
approximately the same at all the polymer concentrations for
both the polymers (Figure 7b and e). When comparing data
from both polymers, the overall yield is higher with PEG for all
conditions tested (almost double for the highest polymer con-
centration at 5 w/v%). This could be due to density differences
between the two polymers and/or that PVA can interfere with
the lipid monolayer or bilayer by incorporating itself across the
membrane. If the concentrations of 2.5–5% PEG or PVA are
not suitable for a particular application, lower concentrations
also yield GUVs. From the confocal images, it is observable
that the GUVs produced with PVA (Figures 7c and S5) and PEG
(Figures 7 f and S6) are morphologically similar to the GUVs
produced by using sugar solutions (Figure 2c) except that the
overall yield is lower. Overall, the use of polymer solutions in-
stead of sugar solutions to produce GUVs is possible using the
inverted emulsion method and PEG is a more promising candi-
date.
Membrane composition and functionality
We aimed to assess the membrane composition for any possi-
ble presence of oil in the lipid bilayer of the GUVs. This is
important for the widespread acceptability and usage of this
technique. Previously, researchers have performed alpha-hemo-
lysin-based assays on GUVs produced by using microfluidic
method to confirm oil-free membranes, unilamellarity and
thus, functionality.[49] We have performed similar experiments
with calcein dye-filled GUVs produced using the inverted emul-
sion method. The plot presented in Figure S7 indicates that
over a period of 30 min, there is a decrease in the calcein fluo-
rescence intensity inside the GUVs in the presence of alpha-he-
molysin. This suggests that the lipid bilayer is oil-free enough
for the membrane protein to incorporate and assemble. This
clearly suggests that the GUV membrane is unilamellar and
functional for the integration of membrane proteins. Further-
more, the fluorescence inside the GUVs remained the same in
the absence of alpha-hemolysin, an observation that also con-
firms the stability (i.e. , no bursting or leakage) of the GUVs.
An ancillary measurement to understand the composition
and purity of lipid membranes is to measure their bending ri-
gidity.[50] Here, we employed the method of fluctuation spec-
troscopy as described in Gracia et al.[51] However, for systems
with high sugar content as used here, one should be aware of
two issues: 1) sugars decrease the bending rigidity of GUV
membranes[50,52,53] and direct comparison with literature data
should take this into account; and 2) at high sucrose/glucose
contrasts, the density difference across the membrane distorts
the vesicle shape and can affect the membrane fluctuation
spectrum leading to errors in the assessed bending rigidity.[54]
Vesicles containing 600 mOsm sucrose in their interior and sus-
pended in equimolar glucose solutions are affected by both of
these effects. To avoid the error associated with gravity, which
often appears to be neglected when comparing inverted
emulsion with electroformed GUVs (see, e.g. , ref. [38]), we
decreased the sucrose/glucose density gradient. For this, the
external GUV solution was adjusted to 575 mm sucrose and
25 mm glucose. This condition ensures no gravity-associated
Figure 7. Plots of yield and size of GUVs obtained when different concentra-
tions of polymers are encapsulated within the inner solution (with glucose
outside). a), b) PVA and d), e) PEG. c), f) Representative confocal images of
the GUVs produced for both the polymers PVA and PEG, respectively (n=3).
Scale bars: 50 mm.
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error as assessed from the gravitational parameter introduced
in Henriken and Ipsen.[54] The data presented in Figure 8 show
that there is no significant difference between the bending ri-
gidities of the GUVs produced using electroformation (1.70:
0.71)V10@19 J and the inverted emulsion (1.42:0.47)V10@19 J
methods. For comparison, we also plot the data obtained with-
out the gravity correction showing an erroneous apparent in-
crease in the bending rigidity. The bending rigidity of inverted-
emulsion-based vesicles appears slightly lower than that of
electroformed vesicles but the difference is not significant
(confirmed with a t-test). These experiments ascertain that the
lipid membranes produced by the inverted emulsion method
are comparable to those of GUVs produced from conventional
techniques.
Conclusion
The inverted emulsion-based method is relatively a new tech-
nique for producing giant vesicles when compared to electro-
formation or gentle hydration. This particular method of pro-
ducing giant vesicles, leaflet-by-leaflet, has series of advantag-
es. Although the major benefit is the possibility to encapsulate
large (bio)molecules inside the GUVs under physiological con-
ditions, the method can be optimized to produce GUVs with
minimum preparation times and for high-throughput analyses.
In this work, we have optimized various parameters to reduce
the time required to produce the GUVs. This was made easy
due to the use of 96-well microtiter plates for parallel prepara-
tions/experiments. Our results demonstrate that density gradi-
ents by using sugars are vitally important in manipulating the
overall yield of the GUVs. Alternatively, polymers, such as PEG
or PVA, can be used to replace inner sugar solutions, if neces-
sary. We have also explored the possibility of using different
oils for solubilizing the lipids because having a homogenous
lipid solution in the carrier oil free from aggregation is impor-
tant for the formation of the interfacial lipid monolayer. From
our findings it is evident that mineral oil is the most suitable
amongst all the other oils (see Table S1 for more details). An-
other significant finding of this work is that, with the exception
of pH 12, there is little effect of pH and temperature on the
yield and size of the GUVs at least for the lipid composition
tried here. This is beneficial for encapsulating components that
are active only at specific pH and temperature conditions. For
example, it is possible to encapsulate enzymes inside the GUVs
at low temperatures when they are inactive and activate them
later under the microscope to study the kinetics of conversion
and the effect of the resultant molecules on the lipid bilayer.
We also note the robustness of using the 96-well plate to per-
form the inverted emulsion procedure. This is evidenced by
the relatively small error bars for each experiment and when
600 mOsm sucrose is used the GUV yields and sizes are compa-
rable across experiments.
When implementing the inverted emulsion method in mi-
crotiter plates, the following conditions can be used for opti-
mal GUV yields: 20 mL of mineral oil with 200 mm lipids to form
the interface over 600 mOsm outer glucose solution for a
period of 30 min. This is followed by 7 mL inner sucrose solu-
tion at 600 mOsm mixed with 250 mL lipid mineral oil to form
the emulsion. Then 50 mL emulsion is added on top of the
interface and subjected to centrifugation at 200g for a period
of 3 min. The total time taken for optimal production of GUVs
is 35 min. We also calculated the minimum time needed to
produce GUVs, which was 18 min by reducing the incubation
period from 30 to 15 min. Note that in this case a suboptimal
number of vesicles is obtained but it is better suited for time-
sensitive experiments.
The most likely hurdle for widespread acceptance of this
technique could be the possibility of oil present in the lipid bi-
layer that could potentially alter the biophysical properties of
the membrane. To this end, we have addressed this concern
(at least for our setup) by incorporating a functionally active
membrane protein. Alpha-hemolysin in its monomeric form in
solution can assemble as a heptamer into the lipid bilayer to
form a pore.[55,56] Not only have we showed that this is possible
within the lipid bilayer of the GUVs produced by using an in-
verted emulsion, but also that the time and concentration re-
quired for total loss of fluorescence inside the GUVs is compa-
rable to that of electroformed GUVs.[26] Along with this assay,
our membrane bending rigidity analysis of these GUVs sup-
ports the conclusion that the GUVs are oil-free (or, at least,
that mineral oil does not alter their mechanical properties) and
are therefore biomimetic. Furthermore, performing the
Figure 8. Bending rigidity measurements of POPC GUVs produced by elec-
troformation (open symbols) and inverted emulsion methods (solid sym-
bols). The vesicle interior contains 600 mOsm sucrose. Data are shown for
preparations where the gravity effects were overcome by replacing the ex-
ternal 600 mOsm glucose solution (black symbols ; hatched area) with a solu-
tion of 25 mOsm glucose and 575 mOsm sucrose (dark cyan). Mean data are
shown with error bars taken from the standard deviation (n+10). Snapshots
above the graph show phase contrast images of GUVs under the respective
conditions. Note that for 600 mOsm glucose in the outer solution, the con-
trast is enhanced due to an increased refractive index difference. Scale bars :
50 mm.
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method in 96-well plates provides the advantage of scalability
for greater statistically significant results and high-throughput
experiments. Overall, we believe that our findings will aid in
the widespread adaptation of this method for membrane stud-
ies where high encapsulation efficiencies, physiological condi-
tions and biomimetic GUVs are required.
Experimental Section
Materials : 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) was purchased from Avanti Lipids Polar, Inc. , Alabaster, AL.
1,1’-Dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate
(DilC18) to label the membranes from Invitrogen, calcein as a fluo-
rescent dye to stain the interiors of GUVs from Thermo Fisher Sci-
entific Inc. Polyvinyl alcohol (PVA), fully hydrolyzed, with a molecu-
lar weight of approximately 145 kDa was purchased from Merck
(Germany) and polyethylene glycol (PEG), with a molecular weight
of approximately 8 kDa crystalline, from Sigma–Aldrich (Germany).
96-Well microtiter plates, optically clear flat bottom, were from
Corning. Alpha-hemolysin, bovine serum albumin (BSA) and b-
casein (from bovine milk) were obtained from Sigma–Aldrich (Ger-
many). Other chemicals including organic solvents (chloroform,
acetone, and ethanol), sugars (glucose and sucrose) and buffers
(PBS, Tris, and HEPES) were purchased from Sigma–Aldrich (Germa-
ny).
Lipids in oil preparation : Chloroform-solubilized POPC (99.9%)
and DilC18 (0.01%) were used to make lipid–oil solution. Briefly,
the preparation of lipid–mineral oil solution starts with forming a
thin film of dried lipids in a clean glass vial by evaporating the
chloroform under argon flow. A desiccator was used to dry the
lipids for a period of 1 h and remove any leftover traces of chloro-
form. Finally, mineral oil was added to the glass vial under low hu-
midity (<10%) conditions using an AtmosBag (Sigma–Aldrich)
filled with nitrogen gas and monitored with a humidity gauge (Kli-
malogg Pro, TFA Dostmann). This was followed by a sonication
step for better solubilization of lipids in the oil. At this stage, the
total concentration of the lipids in the mineral oil can be from 50
to 600 mm, depending on the amount of mineral oil added. The
lipid–mineral oil solution was then incubated overnight at room
temperature in the dark to ensure that the lipids are completely
dissolved. These lipid–oil solutions can be stored for up to one
week at 4 8C and brought to room temperature before usage.
Surface treatment of the microtiter well plates : To achieve high-
throughput and parallelized experiments, the entire inverted emul-
sion method has been performed in 96-well microtiter plate. Sur-
face treatment of the glass bottom of the wells is important to
avoid adhesion and bursting of the GUVs. Wells within the plates
are pre-coated using aqueous solutions of b-casein (2 mgmL@1).
Typically, 30 mL of the coating solution was added to each well and
allowed to dry in the presence of vacuum for 30 min. The well was
gently washed multiple times with the outer solution before
making the lipid interface. BSA at 2 mgmL@1 was used as a coating
material in experiments involving high (12) or low (4) pH where
the b-casein coating is not stable.[57]
Inner and outer aqueous solutions : All aqueous solutions were
made using MilliQ MilliporeS water. Inner solutions contained
either sucrose (50, 300, 600, and 900 mm) or PEG or PVA at 0.5, 1,
2.5, 5 w/v%. For pH-based experiments, the solutions were buf-
fered by using HEPES at 20 mm concentration and NaOH as well as
acetic acid were used to adjust the pH. Inner solutions were also
made with either HEPES (50, 100, 200, 400 mm), Tris (50, 100, 200,
400 mm), or PBS, and sucrose was added to provide enough densi-
ty. For all the above inner solutions, corresponding concentrations
of glucose solutions were used as the outer solutions to maintain
isoosmotic conditions across the membrane.
Inverted emulsion method : Initially, 50 mL of glucose (outer) solu-
tion were added to the pre-coated wells in the microtiter plate.
This was followed by the addition of 20 mL of the lipid–oil mixture
on top of the glucose. The entire setup was allowed to incubate
for a period of 5, 15, 30, or 60 min to form an interfacial lipid mon-
olayer (surface area of ~192 mm2). Then 250 mL of the same lipid–
oil mixture were added to a 1.5 mL EppendorfS tube. To this tube,
1, 3, 5, 7, 10, or 25 mL inner solution were added and then agitated
mechanically along a standard Eppendorf tube rack to yield a
water-in-oil emulsion. Note that four emulsion preparation tech-
niques were compared. Figure S8 shows that mechanical agitation
yields the narrowest size distribution compared to vortexing and
pipetting by hand. Sonication did not provide any useable drop-
lets. We also show that the sizes of the emulsions result in similar
sizes of the final GUVs (Figure S8b). Based on these findings and
the fact that sonication and vortexing can cause protein degrada-
tion, we used mechanical agitation in this work, but for some ap-
plications vortexing may be sufficient. An aliquot of 50 mL of the
emulsion was pipetted into the wells containing the lipid monolay-
er interface. Immediately after this, the microtiter plate was trans-
ferred into a centrifuge. Based on the experiment either 50, 100,
200, 300, 400, 600, or 1200g force was applied for periods of 30 s,
1 min, 3 min, or 10 min.
Membrane composition and functionality : GUVs containing
10 mm of the fluorescent dye calcein were incubated with
2.5 mgmL@1 alpha-hemolysin for a period of 30 min. Confocal fluo-
rescence images were acquired before and after the assay. For
bending rigidity measurements, GUVs containing 600 mOsm su-
crose inside and 600 mOsm glucose outside were prepared by
using the inverted emulsion method and then diluted with sucrose
to achieve an out solution of 575 mOsm sucrose and 25 mOsm
glucose as required. Electroformed GUVs were produced by using
a procedure explained elsewhere with minor modifications: 2 Vp-p
at 10 Hz for a period of 3 h in 600 mOsm sucrose and diluted as
above when required.[55] Measurements and subsequent analysis
for bending rigidity measurements have been performed by using
the methods developed by Garcia et al.[51] Acquisitions were per-
formed by using an inverted microscope (Axiovert 135 Zeiss, Ger-
many) equipped with 20V objective and a fast digital camera
(eCMOS PCO.edge, PCO AG, Germany) with an exposure time of
200 ms at 20 frames per second.
Microscopy : The produced GUVs can be directly observed within
the microtiter plate using an inverted microscope without any fur-
ther sample preparation. Here, the samples were observed and
images acquired using a confocal microscope (Leica microsystems
TCS SP8, Wetzlar, DE) equipped with a 63V /1.4 NA water immer-
sion objective. A total of six confocal images were randomly taken
in each well and with the same field of view for comparable yield
assessments. The diameter and population of individual GUVs were
measured using the Vesicle-Analyser-Pro software.[58] Note that
multiple z-stacks were acquired at each position to ensure all vesi-
cles were imaged and that each vesicle was measured at the equa-
torial plane. GUVs with diameters below 10 mm were excluded.
DiIC18 fluorescence in the membrane was excited by using a
552 nm diode laser with emission collected at 562–635 nm and
calcein present inside the GUVs by a 488 nm diode laser with emis-
sion collected at 498–535 nm.
ChemBioChem 2019, 20, 2674 – 2682 www.chembiochem.org T 2019 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim2681
Full Papers
Acknowledgements
The authors would like to acknowledge Hjçrtur Hjartarson for
providing the software for data analysis, and Vasil Georgiev for
help with the fluctuation analysis. We acknowledge Reinhard Lip-
owsky for institutional and financial support. This work is part of
the MaxSynBio consortium which is jointly funded by the Federal
Ministry of Education and Research of Germany and the Max
Planck Society. Open Access funding provided by the Max Planck
Society.
Conflict of Interest
The authors declare no conflict of interest.
Keywords: biomimetic · bottom-up synthetic biology · giant
unilamellar vesicles · inverted emulsion · phase transfer ·
physiological buffers
[1] P. Schwille, J. Spatz, K. Landfester, E. Bodenschatz, S. Herminghaus, V.
Sourjik, T. J. Erb, P. Bastiaens, R. Lipowsky, A. Hyman, et al. , Angew.
Chem. Int. Ed. 2018, 57, 13382–13392; Angew. Chem. 2018, 130, 13566–
13577.
[2] P. Walde, BioEssays 2010, 32, 296–303.
[3] R. Dimova, S. Aranda, N. Bezlyepkina, V. Nikolov, K. A. Riske, R. Lipowsky,
J. Phys. Condens. Matter 2006, 18, S1151–S1176.
[4] P. Walde, K. Cosentino, H. Engel, P. Stano, ChemBioChem 2010, 11, 848–
865.
[5] R. Dimova, Annu. Rev. Biophys. 2019, 48, 93–119.
[6] S. Deshpande, C. Dekker, Nat. Protoc. 2018, 13, 856–874.
[7] T. Robinson, Adv. Biosyst. 2019, 3, 1800318.
[8] H. T. McMahon, E. Boucrot, J. Cell Sci. 2015, 128, 1065–1070.
[9] M. Kurylowicz, H. Paulin, J. Mogyoros, M. Giuliani, J. R. Dutcher, J. R. Soc.
Interface 2014, 11, 20130818.
[10] B. Daum, A. Auerswald, T. Gruber, G. Hause, J. Balbach, W. Kehlbrandt,
A. Meister, J. Struct. Biol. 2016, 194, 375–382.
[11] P. Bassereau, R. Jin, T. Baumgart, M. Deserno, R. Dimova, V. A. Frolov,
P. V. Bashkirov, H. Grubmeller, R. Jahn, H. J. Risselada, et al. , J. Phys. D.
Appl. Phys. 2018, 51, 34.
[12] T. Robinson, P. E. Verboket, K. Eyer, P. S. Dittrich, Lab Chip 2014, 14,
2852.
[13] A. Basu, P. Maity, P. Karmakar, S. Karmakar, J. Surf. Sci. Technol. 2016, 32,
85–92.
[14] H. Stein, S. Spindler, N. Bonakdar, C. Wang, V. Sandoghdar, Front. Physiol.
2017, 8, 63.
[15] F. Kong, X. Zhang, M. Hai, Langmuir 2014, 30, 3905–3912.
[16] J. Hou, B. Belardi, D. A. Fletcher, M. D. Vahey, J. Wang, S. Son, J. Cell Sci.
2018, 132, jcs221556.
[17] T. Trantidou, M. S. Friddin, A. Salehi-Reyhani, O. Ces, Y. Elani, Lab Chip
2018, 18, 2488–2509.
[18] A. S. Utada, E. Lorenceau, D. R. Link, P. D. Kaplan, H. A. Stone, D. A.
Weitz, Science 2005, 308, 537–541.
[19] S.-Y. Teh, R. Khnouf, H. Fan, A. P. Lee, Biomicrofluidics 2011, 5, 044113.
[20] S. Deshpande, Y. Caspi, A. E. C. Meijering, C. Dekker, Nat. Commun.
2016, 7, 10447.
[21] M. Abkarian, E. Loiseau, G. Massiera, Soft Matter 2011, 7, 4610–4614.
[22] D. L. Richmond, A. P. Liu, T. H. Li, J. C. Stachowiak, S. H. Parekh, D. A.
Fletcher, Proc. Natl. Acad. Sci. USA 2008, 105, 4697–4702.
[23] M. Weiss, J. P. Frohnmayer, L. T. Benk, B. Haller, J. W. Janiesch, T. Heit-
kamp, M. Bçrsch, R. B. Lira, R. Dimova, R. Lipowsky, et al. , Nat. Mater.
2018, 17, 89–96.
[24] D. Van Swaay, A. Demello, Lab Chip 2013, 13, 752–767.
[25] K. Nishimura, H. Suzuki, T. Toyota, T. Yomo, J. Colloid Interface Sci. 2012,
376, 119–125.
[26] T. Robinson, P. Kuhn, K. Eyer, P. S. Dittrich, Biomicrofluidics 2013, 7,
044105.
[27] N. N. Deng, M. Yelleswarapu, W. T. S. Huck, J. Am. Chem. Soc. 2016, 138,
7584–7591.
[28] T. Okano, K. Inoue, K. Koseki, H. Suzuki, ACS Synth. Biol. 2018, 7, 739–
747.
[29] T. Litschel, K. A. Ganzinger, T. Movinkel, M. Heymann, T. Robinson, H.
Mutschler, P. Schwille, New J. Phys. 2018, 20, 055008.
[30] M. Tsugane, H. Suzuki, Sci. Rep. 2018, 8, 7934.
[31] T. Trantidou, L. Dekker, K. Polizzi, O. Ces, Y. Elani, Interface Focus 2018, 8,
https://doi.org/10.1098/rsfs.2018.0024.
[32] Y. Natsume, H. Wen, T. Zhu, K. Itoh, L. Sheng, K. Kurihara, J. Vis. Exp.
2017, 1–8.
[33] K. Tsumoto, Y. Hayashi, J. Tabata, M. Tomita, Colloids Surf. A 2018, 546,
74–82.
[34] K. Karamdad, J. W. Hindley, G. Bolognesi, M. S. Friddin, R. V. Law, N. J.
Brooks, O. Ces, Y. Elani, Chem. Sci. 2018, 9, 4851–4858.
[35] V. Noireaux, A. Libchaber, Proc. Natl. Acad. Sci. USA 2004, 101, 17669–
74.
[36] E. A. Kubatta, H. Rehage, Colloid Polym. Sci. 2009, 287, 1117–1122.
[37] S. Pautot, B. J. Frisken, D. A. Weitz, Langmuir 2003, 19, 2870–2879.
[38] Y. Elani, S. Purushothaman, P. J. Booth, J. M. Seddon, N. J. Brooks, R. V.
Law, O. Ces, Chem. Commun. 2015, 51, 6976–6979.
[39] L. Lu, W. J. Doak, J. W. Schertzer, P. R. Chiarot, Soft Matter 2016, 12,
7521–7528.
[40] Y. Elani, R. V. Law, O. Ces, Nat. Commun. 2014, 5, 5305.
[41] L. Harvey, B. Arnold, S. L. Zipursky, M. Paul, B. David, D. James, Molecular
Cell Biology, 4th ed., 2000.
[42] O. Wesołowska, K. Michalak, J. Maniewska, A. B. Hendrich, Acta Biochim.
Pol. 2009, 56, 33–39.
[43] A. D. Petelska, Z. A. Figaszewski, Biophys. J. 2000, 78, 812–817.
[44] M. Repetto, J. Semprine, A. Boveris, Lipid Peroxidation: Chemical Mecha-
nism, Biological Implications and Analytical Determination, 2012, DOI:
https://dx.doi.org/10.5772/45943.
[45] S. Lowe, N. M. O’Brien-Simpson, L. A. Connal, Polym. Chem. 2015, 6,
198–212.
[46] A. Weinberger, F. C. Tsai, G. H. Koenderink, T. F. Schmidt, R. Itri, W. Meier,
T. Schmatko, A. Schrçder, C. Marques, Biophys. J. 2013, 105, 154–164.
[47] Y. Li, R. Lipowsky, R. Dimova, Proc. Natl. Acad. Sci. USA 2011, 108, 4731–
4736.
[48] Y. Liu, J. Agudo-Canalejo, A. Grafmeller, R. Dimova, R. Lipowsky, ACS
Nano 2016, 10, 463–474.
[49] S. Deshpande, Y. Caspi, A. E. C. Meijering, C. Dekker, Nat. Commun.
2016, 7, 10447.
[50] R. Dimova, Adv. Colloid Interface Sci. 2014, 208, 225–234.
[51] R. S. Graci/, N. Bezlyepkina, R. L. Knorr, R. Lipowsky, R. Dimova, Soft
Matter 2010, 6, 1472–1482.
[52] V. Vitkova, J. Genova, M. D. Mitov, I. Bivas, Mol. Cryst. Liq. Cryst. 2006,
449, 95–106.
[53] P. Shchelokovskyy, S. Tristram-Nagle, R. Dimova, New J. Phys. 2011, 13,
025004.
[54] J. R. Henriksen, J. H. Ipsen, Eur. Phys. J. E 2002, 9, 365–374.
[55] N. Yandrapalli, T. Robinson, Lab Chip 2019, 19, 626–633.
[56] L. Song, M. R. Hobaugh, C. Shustak, S. Cheley, H. Bayley, J. E. Gouaux,
Science 1996, 274, 1859–1865.
[57] C. A. Zittle, J. Dairy Sci. 1966, 49, 361–364.
[58] H. Hjartarson, 2019, https://doi.org/10.5281/zenodo.2592469.
Manuscript received: August 26, 2019
Accepted manuscript online: September 17, 2019
Version of record online: && &&, 0000
ChemBioChem 2019, 20, 2674 – 2682 www.chembiochem.org T 2019 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim2682
Full Papers
